Project Details
Description
A Randomized Phase III Study of Weekly ABI-007 plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Status | Finished |
---|---|
Effective start/end date | 2/1/09 → 6/30/13 |
Funding
- ABRAXIS BIOSCIENCE, LLC